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Summary
 
Natural killer (NK) cells preferentially lyse targets that express reduced levels of major histo-
compatibility complex (MHC) class I proteins. To date, the only known mouse NK receptors
for MHC class I belong to the Ly49 family of C-type lectin homodimers. Here, we report the
cloning of mouse NKG2A, and demonstrate it forms an additional and distinct class I receptor,
a CD94/NKG2A heterodimer. Using soluble tetramers of the nonclassical class I molecule Qa-
1
 
b
 
, we provide direct evidence that CD94/NKG2A recognizes Qa-1
 
b
 
. We further demonstrate
that NK recognition of Qa-1
 
b
 
 results in the inhibition of target cell lysis. Inhibition appears to
depend on the presence of Qdm, a Qa-1
 
b
 
-binding peptide derived from the signal sequences of
some classical class I molecules. Mouse NKG2A maps adjacent to CD94 in the heart of the NK
complex on mouse chromosome six, one of a small cluster of NKG2-like genes. Our findings
suggest that mouse NK cells, like their human counterparts, use multiple mechanisms to survey
class I expression on target cells.
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S
 
everal independent mechanisms have been described by
which certain tumors or pathogens downregulate MHC
class I expression (1, 2), thereby circumventing immune
recognition by cytotoxic T cells. The ability of NK cells to
distinguish and lyse targets that express reduced surface lev-
els of MHC class I genes may thus provide protection
against such tumors and pathogens (3). In mice, the Ly49
family of class I–specific receptors has provided a substantial
molecular basis for the detection of MHC class I by NK
cells (4, 5), but some inconsistencies remain. For instance,
some murine NK cell lines that lack detectable expression
of Ly49 molecules spare class I
 
1
 
 tumor targets from lysis,
but kill their matched class I
 
2
 
 variants (6, 7).
A further reason for supposing that class I recognition by
mouse NK cells may not be solely via Ly49 receptors is that
human NK cells express two distinct families of receptors
for class I: immunoglobulin-like receptors that directly
bind to certain HLA-A, B and C alleles (reviewed in refer-
ence 8) and lectin-like heterodimers of NKG2 family
members and CD94 (9–12). The cytoplasmic domain of
CD94 is only 10 amino acids in length (13), so the signal-
ing capacity of CD94/NKG2 heterodimers is presumably
mediated through the various NKG2 molecules (14). NKG2A
contains two immunoreceptor tyrosine-based inhibitory
motifs (ITIMs)
 
1
 
 and transmits inhibitory signals (15). NKG2C
and E lack ITIMs, and at least NKG2C activates NK cells,
probably through its association with a small signaling
homodimer, DAP12 (16). CD94/NKG2A and CD94/
NKG2C heterodimers were recently shown (17–20) to
bind directly to HLA-E, a nonclassical MHC class I mole-
cule. No definitive explanation has been offered as to why
the human class I specific receptors should differ so strik-
ingly from those of the mouse, but a popular supposition
has been that class I-specific receptors on NK cells are a re-
cent evolutionary phenomenon that has been driven by the
rapid evolution of class I molecules themselves (21). Alter-
 
R.E. Vance and J.R. Kraft contributed equally to this work.
 
1
 
Abbreviations used in this paper:
 
 APC, allophycocyanin; BAC, bacterial ar-
tificial chromosomes; HA, hemagglutinin; ITIM, immunoreceptor ty-
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otide; TAP, transporter associated with antigen presentation.
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natively, it remains possible that humans and mice share
most or all families of NK class I receptors, and that these
receptors will eventually be discovered and characterized.
Previously, we and others identified a gene homologous
to human CD94 that is expressed by mouse NK cells (22,
23). We demonstrated that mouse CD94 maps within a re-
gion of chromosome six dubbed the NK complex (24),
near other NK-expressed genes including CD69, NKR-
P1, and Ly49. CD94 and NKG2A/C genes have also been
identified in the rat (25, 26), and map to the corresponding
rat NK complex. Rodent NKG2D-like sequences also ex-
ist (22, 23, 27), but the significance of these sequences is
uncertain because human NKG2D is not in the same ho-
mology cluster as other NKG2 genes and does not appear
to associate with CD94. Unlike human CD94, rodent
CD94 molecules contain a positively charged amino acid in
their transmembrane domains, suggesting that the structure
of any CD94-containing complexes may differ among
species. Moreover, no interaction of rodent CD94/NKG2
molecules with MHC class I has been reported to date,
leaving open the question of whether rodent and human
CD94/NKG2 molecules are true functional homologues.
The class I ligand for human CD94/NKG2A and C het-
erodimers, HLA-E, is interesting because it appears to asso-
ciate predominantly with peptides derived from the signal
sequences of classical class I proteins (28, 29). In the mouse,
the nonclassical class I molecule Qa-1
 
b
 
 has been found
preferentially associated with a peptide called Qdm
(AMAPRTLLL), also derived from class I signal sequences
(30–32). Although Qa-1 and HLA-E bind signal peptides
that are cleaved in the ER, proper loading of these peptides
into Qa-1 or HLA-E appears to depend on the transporter
associated with antigen presentation (TAP), a complex that
shuttles peptides from the cytoplasm into the ER (28, 33).
As a consequence, NK cells could detect defects in class I
expression or TAP function resulting from infection or
tumorigenesis simply by monitoring the surface expression
of Qa-1/HLA-E and associated peptides.
Although Qa-1
 
b
 
 and HLA-E both exhibit a preference
for TAP-dependent signal peptides, it should be empha-
sized that sequence alignments do not make a compelling
case that HLA-E and Qa-1
 
b
 
 are true homologues (33).
Such a case would be strengthened if it could be demon-
strated that HLA-E and Qa-1 play similar functional roles.
Here, we report the cloning of mouse NKG2A and docu-
ment the direct and functional interaction of CD94/
NKG2A heterodimers with Qa-1
 
b
 
/Qdm complexes on
target cells. Our results demonstrate for the first time the
existence of a functionally conserved mechanism by which
NK cells can monitor class I expression on target cells.
 
Materials and Methods
 
Primers and PCR.
 
PCR was performed with either 
 
Pfu
 
 Poly-
merase (Stratagene, La Jolla, CA) or 
 
Taq
 
 Polymerase (Promega
Corp., Madison, WI) using 30–35 cycles as follows: 92
 
8
 
C for 60 s,
55
 
8
 
C for 60 s, and 72
 
8
 
C for 30 s. Primers were as follows (nucle-
otide [nt] 1 is the first translated base; lower case bases are restric-
 
tion enzyme sites, Kozak sequences, etc.): mNKG2C 3
 
9
 
 no. 1 
 
5
 
tactcgagTCAGATGGGGAATTTACACTTACAAAGATATGG
(nt 703–735); mNKG2A 3
 
9
 
 no. 4 
 
5 
 
CTGCAGATCCAGG-
GATGCTCC (nt 150–170); mNKG2A 5
 
9
 
UTR 
 
5 
 
CTTTGC-
CTCAGCACATCACTAGCTG (nt 
 
2
 
30 to 
 
2
 
6); mNKG2A
3
 
9
 
UTR 
 
5 
 
CCTGGCAGACTTCCAGTGC(A/G)GGTGTTTCA
(nt 733–761); CD94 3
 
9
 
STOP 
 
5 
 
atggatccgcggccgcTCAAATAG-
GCAGTTTCTTACAGATG (last 25 nt of mCD94); mNKG2A
5
 
9
 
 
 
5 
 
atcatcgatctcgagccaccATGTCCAATGAACGCGTCACCT-
ATGCAGAACTGAAGGTGGCAAAGAACTCAAGG (encodes
a Kozak sequence and the first 18 amino acids of mouse NKG2A,
although some of the nucleotide wobble positions are not cor-
rect); mNKG2A HA Not3
 
9
 
 
 
5 
 
tatagcggccgcTCAGGCGTAG-
TCGGGCACGTCGTAGGGGTAGATGGGGAATTTACACT-
TACAAAG (encodes a COOH-terminal hemagglutinin epitope
tag [YPYDVPDYA; underlined]); mNKG2A 5
 
9
 
ex5 
 
5 
 
GCACAG-
CCTTGTCCTCATTGTCC (nt 364–386); mNKG2A 3
 
9
 
ex6 
 
5
 
GGTTTGAAAATTGAGACTTCTTTCC (nt 590–614).
 
Bacterial Artificial Chromosomes.
 
110,592 bacterial artificial chro-
mosomes (BAC) clones derived from C57BL/6 genomic DNA
were screened on six high density nylon filters (Genome Systems,
St. Louis, MO) with mCD94 3
 
9
 
 and mNKG2D cDNA probes
(22). We focused on three positive BACs (Genome Systems
clone addresses: 189c16, 91i19, and 89b4). BACs were grown in
LB supplemented with 12.5 
 
m
 
g/ml of chloramphenicol (C-0378;
Sigma Chemical Co., St. Louis, MO) and were purified over
midi columns (QIAGEN Inc., Chatsworth, CA). The sizes of the
BAC inserts (released by NotI digestion) were estimated by
pulsed field gel electrophoresis.
 
Cloning of Mouse NKG2A and Expression Constructs.
 
Exons 5-7
of human NKG2A were amplified by RT-PCR from IL-2 cul-
tured PBL RNA, and used as a probe on Southerns of three BACs
(see above) previously shown to contain mouse CD94 and/or
mouse NKG2D. Exceedingly weak hybridization to three different
HindIII fragments of 
 
z
 
3.5 kb, 9 kb, and 
 
.
 
20 kb was detected.
The 3.5- and 9-kb fragments were cloned into pBluescript
SKII(
 
1
 
) to generate plasmids B6/H3.5 and B6/H9, respectively,
that were partially sequenced using the T3 and T7 primers.
Sequence with significant homology to NKG2C (exons 4 or 7)
was obtained and used to design a 3
 
9
 
 primer (NGK2C 3
 
9
 
 no. 1) for
amplification of full-length cDNA by the same strategy we used to
clone mouse CD94 (22). In brief, 100 ng of a CB17.SCID lym-
phocyte plasmid cDNA library (gift of P.A. Matthew and V. Kumar,
University of Texas, Dallas, TX) was used as the template in a
PCR reaction with a 5
 
9
 
 primer that recognizes the plasmid vector
and a 3
 
9
 
 primer that is specific for the cDNA of interest. PCR
products were cloned into the pGEM T-easy vector (Promega
Corp.) but none of the resulting clones contained full-length
cDNA and were either lacking the extreme 5
 
9
 
 end, or internal ex-
ons. To obtain the 5
 
9
 
 end of mouse NKG2A, we sequenced BAC
89b04 in the 3
 
9
 
 direction using the mNKG2A 3
 
9
 
 no. 4 primer, and
the resulting sequence was used to design a primer (mNKG2A
5
 
9
 
UTR) which could be used with the mNKG2A 3
 
9
 
UTR primer
to amplify the complete ORF of mNKG2A from B6 LAK cDNA.
Expression constructs were based on the pME18S expression vec-
tor. pME-CD94-HA has been described previously (22). pME-
CD94 (untagged) was produced using primers CD94 5
 
9
 
 Xho-Koz
(22) and CD94 3
 
9
 
STOP. pME-NKG2A was produced using prim-
ers mNKG2A 5
 
9
 
 and mNKG2A 3
 
9
 
 no. 1. pME-NKG2A-HA was
produced using primer mNKG2A 5
 
9
 
 and mNKG2A HA Not3
 
9
 
.
All inserts were amplified with 
 
Pfu
 
 polymerase, cloned into the
XhoI and NotI sites of pME18S, and confirmed by sequencing.
Transfections into COS7 cells were as described previously (22). 
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Southern Blotting and Probes.
 
Southern blotting and the CD94
3
 
9
 
 probe were as described previously (22). The 95R probe has
been described (24). The NKG2D probe corresponds to the insert
in IMAGE consortium clone 621324 (these data are available from
GenBank/EMBL/DDBJ under accession number AF030313). The
NKG2A exon 5/6 probe corresponds to nucleotides 364–614 of
mNKG2A (predicted exons 5 and 6) and was generated by PCR
with primers mNKG2A 5
 
9
 
ex5 and mNKG2A 3
 
9
 
ex6. The
NKG2A 5
 
9
 
 probe was generated from the 5
 
9
 
 end of the NKG2A
cDNA (nucleotides 1–398, numbering starting at ATG).
 
Synthesis of Qa-1
 
b
 
 Tetramers.
 
Expression vectors were con-
structed using PCR to amplify soluble Qa-1
 
b
 
 from a full-length
Qa-1
 
b
 
 cDNA (34). The oligonucleotide primers gagatatacatatg-
GAGCCCACACTCGCTGCGGT and gcagggatccGGATGGAG-
GAGGCTCCCATCT were used for this amplification (NdeI
and BamHI sites underlined). The digested Qa-1
 
b
 
 PCR fragment
was ligated into pET-23a(
 
1
 
)-D
 
b
 
-BSP (35), cut with the same en-
zymes (removing D
 
b
 
) to create pET23-sQa-1b-BSP. After se-
quence verification, the vector was transformed into 
 
Escherichia
coli
 
 BL21 (DE3)pLysS. sQa-1
 
b
 
-BSP and human 
 
b
 
2m (36) were
purified and refolded as described (37, 38). In brief, six liters of
cells were induced with IPTG and the cells were lysed. Inclusion
bodies were purified by washing with a Triton X-100 solution
and solubilized in urea. The sQa-1
 
b
 
-BSP was folded in vitro with
 
b
 
2m and Qdm peptide (AMAPRTLLL) and purified on a Phar-
macia s300 gel filtration column (Pharmacia Biotech, Inc., Piscat-
away, NJ). The Qa-1
 
b
 
/
 
b
 
2m/Qdm complex was biotinylated
with the BirA enzyme as described (37), purified on a UnoQ ion
exchange column (Bio-Rad Laboratories, Hercules, CA), and
tetramerized with streptavidin-APC (Molecular Probes Inc., Eu-
gene, OR) in a 4:1 molar ratio.
 
Mice, Antibodies and Flow Cytometry.
 
C57BL/6 mice were
bred in the University of California Berkeley Animal Facility
from founders purchased from The Jackson Laboratories (Bar
Harbor, ME). Other strains of mice were purchased directly from
The Jackson Laboratories. FcR blocking and staining with vari-
ous NK mAbs was as previously described (39). Other mAbs in-
cluded unconjugated anti-HA ascites (Babco Antibody Co., Berke-
ley, CA), PE-conjugated donkey anti–mouse IgG secondary (The
Jackson Laboratories), FITC conjugated swine anti–rabbit F(ab
 
9
 
)
 
2
 
polyclonal (DAKOPATTS, Copenhagen, Denmark), and FITC-
conjugated anti-CD3 (clone 500A2). Purified IgG fraction of
rabbit antisera generated with a synthetic peptide from the 
 
a
 
2
domain of Qa-1
 
b
 
 was generously provided by Dr. Mark Soloski
(The Johns Hopkins School of Medicine, Baltimore, MD).
Samples to be stained with tetramer were preblocked with 0.5
mg/ml unconjugated streptavidin (Molecular Probes, Inc.) for
15 min. Splenocytes were RBC depleted and nylon wool passed
(Robbins Scientific, Sunnyvale, CA) before staining in PBS/5%
FCS/0.02% sodium azide on ice. Flow cytometric analysis and
sorting were performed on Coulter XL-MCL and EPICS Elite
machines at the University of California Berkeley Flow Cytom-
etry Facility.
 
IL-2 Cultured NK Cells, Chromium Release Assay and Peptides.
 
Culture of IL-2 cultured NK cells (LAK) cells and the 
 
51
 
Cr re-
lease assay were performed essentially as described previously
(40), with the following differences. Qa-1 tetramer positive or
negative NK cells (NK1.1
 
1
 
CD3
 
2
 
) were sorted on day 2 of cul-
ture, returned to IL-2 media, and assayed on day 5. The range of
triplicate values were usually less than 
 
6
 
4% of specific lysis. T2
transfectants expressing Qa-1
 
b
 
 (T2-g37; references 41, 42) were
the gift of Dr. Mark Soloski. T2 transfectants expression IA
 
b
 
(T2-BB; reference 43) were obtained from Dr. Ned Braunstein
(Columbia University College of Physicians and Surgeons, New
York, NY). The Qdm (AMAPRTLLL) and Ova (SIINFEKL)
peptides were synthesized and purified by the University of Cali-
fornia Berkeley Microchemical Facility, and were verified by
mass spectrometry. Peptides were added to target cells overnight
at 26
 
8
 
C at a concentration of 30 
 
m
 
M, and were also included dur-
ing incubations at 37
 
8
 
C required to label targets with 
 
51
 
Cr (1 h)
or to perform the cytolysis assay (4 h).
 
Results and Discussion
 
A human NKG2 probe was employed to detect weakly
cross-hybridizing fragments on several CD94-containing
BACs isolated from a B6 genomic library. These cross-
hybridizing fragments were subcloned, partially sequenced,
and were found to contain sequence homologous to hu-
man NKG2 exons. A PCR-based strategy was then used to
obtain cDNA encoding full length homologues of NKG2A
(Fig. 1). Mouse NKG2A has sequence similarity to the
group of C-type lectin-like receptors on NK cells, which
includes CD69, NKR-P1, and Ly49, but most resembles
human and rat NKG2A (60.5 and 85.7% similarity, respec-
tively, at the protein level; references 14, 25). An inhibitory
signaling function for mouse NKG2A is suggested by the
presence of one and possibly two conserved motifs in the cy-
toplasmic tail (VTYAEL and IIYSDF) that resemble the
consensus ITIM (V/IxYxxV/L). This motif is present in all
known inhibitory NK receptors, and has been shown to
interact with tyrosine phosphatases such as SHP-1 (44).
Figure 1. Comparison of mouse (m), rat (r), and human (h) NKG2A
protein sequences, as deduced from the cDNA sequences, using the
Clustal W algorithm (v 1.6; reference 52). Identical residues are joined by
a vertical line and similar residues are joined by a colon. The exon struc-
ture of the human NKG2A gene is shown, as determined previously (53).
Potential or actual ITIM are shaded, as are the predicted transmembrane
domains and potential N-linked glycosylation sites (*). The mouse
NKG2A nucleotide sequence is available from GenBank under accession
number AF095447.1844 Mouse CD94/NKG2A Is a Natural Killer Receptor for Qa-1b
Northern blot analysis showed strong NKG2 expression in
IL-2 cultured NK cells (LAKs), but not in total lymph
node, spleen, kidney, thymus, heart, or testis, suggesting
that NKG2 expression is relatively NK-specific (data not
shown).
To address whether there are multiple NKG2 genes in
the mouse, a Southern blot of total genomic DNA from
several inbred strains of mice was probed with predicted
exons 5 and 6 of mouse NKG2A. In the human, exons 5,
6, and 7 are highly (.90%) conserved among NKG2A, C,
and E, so we expected the probe to cross-hybridize with
additional mouse NKG2 genes, should they exist. Indeed,
hybridization of the probe to multiple genomic fragments
was observed, consistent with the possibility that mice, like
humans, might contain a small family of NKG2-related
molecules (Fig. 2 A). Several strains of mice, including
BALB/c, DBA/2J, and CBA/J, exhibited a Southern blot
pattern different than that of B6, demonstrating that the
NKG2 locus is polymorphic. Direct evidence that the mul-
tiple bands represent multiple genes was obtained by par-
tially sequencing two cloned nonoverlapping B6 genomic
fragments (B6/H3.5 and B6/H9; see Materials and Meth-
ods). Each fragment contained an additional NKG2-related
exon most similar to human NKG2C (exon 4). Partial
cDNAs corresponding to the sequences in these exons have
been isolated (data not shown), suggesting that these addi-
tional genes are also transcribed by mouse NK cells.
The exon 5/6 probe, as well as probes specific for addi-
tional NK complex markers, were then hybridized to a se-
ries of BACs that overlap in the region of the NK complex
on mouse chromosome six (Fig. 2 B). The exon 5/6 probe
detected multiple fragments of sizes similar to those de-
tected on Southern blots of total mouse genomic DNA. In
contrast, the NKG2A 59 probe appeared to be relatively
specific for a single locus, suggesting that, as in the human,
the 59 (cytoplasmic) domains of mouse NKG2 genes are
relatively divergent. Because each BAC contained a differ-
ent number of NKG2 exon 5/6 hybridizing fragments, and
only BAC 89b04 produced strong hybridization to an
NKG2A 59 probe, a proposed structure for the mouse
CD94/NKG2 locus could be determined (Fig. 2 C). With-
out NKG2C or NKG2E-specific probes, the number of
NKG2C related sequences remains uncertain, but there ap-
pears to be at least two. Interestingly, the mouse NKG2
genes are tightly clustered within an z100-kb region be-
tween CD69 (centromerically) and the Ly49 family (telo-
merically), with NKG2A being the most telomeric NKG2
gene.
To investigate whether mouse CD94/NKG2A recog-
nizes Qa-1b, soluble complexes of Qa-1b/b2m/Qdm were
tetramerized with streptavidin allophycocyanin (APC), per-
mitting their use as high avidity staining reagents (37).
COS7 cells were then transiently transfected with hemag-
glutinin (HA) epitope-tagged versions of NKG2A and/or
CD94. Appreciable surface expression of individually trans-
fected NKG2A-HA or CD94-HA was detected with anti-
HA mAb on a subset of transfectants (Fig. 3), but the Qa-1b
tetramers did not bind to these cells, nor to COS7 cells ex-
pressing either untagged CD94 or NKG2A. Strikingly,
however, cotransfection of CD94 and NKG2A resulted in
strong binding to Qa-1b tetramers, providing direct support
for the notion that CD94 and NKG2A together form a re-
ceptor for Qa-1b. The tetramer did not bind to COS7 cells
transfected with any of the known Ly49 cDNAs (Hanke,
T., and D.H. Raulet, unpublished results).
Significantly, the Qa-1b tetramers were produced in E.
coli and are consequently not glycosylated; thus, although
CD94 and NKG2A exhibit homology to lectin-like recep-
tors, they appear capable of recognizing carbohydrate-inde-
pendent epitopes on their ligands, a situation akin to that of
human CD94/NKG2 (20) and also mouse Ly49A (45).
Carbohydrate recognition may nevertheless play a role in
increasing the affinity of the CD94/NKG2A-Qa-1 interac-
tion. As a further note, it has been reported that without
CD94, human NKG2 molecules are not efficiently ex-
pressed on the cell surface (9, 10). In contrast, we observe
substantial surface expression of NKG2A in the absence of
CD94. It remains possible that surface expression of
mNKG2A without CD94 is the result of the abnormally
high levels of expression that occurs in our COS7 transfec-
Figure 2. The NKG2 multi-gene family genomic structure. (A) Tail
genomic DNA was isolated from the indicated strains of inbred mice, di-
gested with EcoRI or BamHI, and Southern blotted with a probe derived
from predicted exons 5 and 6 of mouse NKG2A. The migration of stan-
dard kilobase markers is shown. (B) Hybridization of NK complex probes
to BACs. Clone numbers (Genome Systems B6 BAC library) and restric-
tion enzymes used in the digest are shown above each lane. NotI was
added to the EcoRV and EcoRI digests to ensure complete release of the
insert; HindIII is sufficient to release the insert. 95R is an NK complex
marker previously derived from the right end of YAC 95E6 (24). See
Materials and Methods for the details of other probes. The NKG2A 59
probe might be weakly cross-reactive with another NKG2 family mem-
ber, as evidenced by its weak hybridization to a 2-kb EcoRV fragment in
BACs 189c16 and 89b04. (C) Proposed structure of the mouse CD94/
NKG2 complex, located on chromosome six between the Nkrp1 and
Cd69 genes (centromerically) and the Ly49 cluster (telomerically). BACs
were ordered on the basis of the hybridization data in B. The number and
order of NKG2C/E genes remains uncertain, and awaits the development
of more specific probes.1845 Vance et al.
tants. As reported previously (22), we also see expression of
mouse CD94 alone on the surface of COS transfectants,
despite the presence of a positive charge in the transmem-
brane domain of CD94. Again, it is not known whether
mouse CD94 is expressed alone on the surface of NK cells,
nor is it known whether the positive charge plays a role in
mediating associations with other membrane proteins.
The Qa-1b tetramer was also used to stain freshly isolated
B6 splenocytes (Fig. 4 A). Specific staining of z30% of NK
cells (NK1.11CD32) was observed. This percentage likely
represents an underestimate since z45% of NK1.11 cells
were tetramer positive in preliminary experiments using a
fresher tetramer preparation that separated a fully distinct
positive population (data not shown). Expression of the
Qa-1 receptor on NK cells partially overlaps with Ly49 ex-
pression (Fig. 4 B), demonstrating additional complexity in
the NK class I receptor repertoire. Weak but reproducible
tetramer binding to a fraction of NK1.11 T cells was also
observed (Fig. 4 A), suggesting a possible role for CD94/
NKG2 receptors in the regulation of certain T cell subsets
(46).
To demonstrate that the interaction of CD94/NKG2A
and Qa-1b is of functional significance, the Qa-1b tetramer
was used as a reagent to sort Qa-1b tetramer positive and
negative NK cell (NK1.11CD32) populations from IL-2
cultured B6 splenocytes. Human TAP-deficient T2 cells
are normally highly susceptible targets for mouse NK cells.
Sorted tetramer positive NK cells were fully lytic, and were
not inhibited by the expression of Qa-1b in T2 target cells.
Figure 3. CD94/NKG2A is a receptor for Qa-1b. Expression con-
structs encoding CD94, NKG2A, or HA epitope-tagged versions of these
proteins, were transiently transfected individually or together into COS7
cells as indicated. After 48 h, cells were lifted with PBS and 0.02% EDTA,
stained either with anti-HA or Qa-1b tetramer, and analyzed by flow cy-
tometry using forward and side scatter to exclude dead cells. The percent-
age of cells within the indicated gate is shown for each sample.
Figure 4. The Qa-1b tetra-
mer predominantly recognizes a
subset of NK cells. (A) B6 sple-
nocytes were enriched for T and
NK cells by passage over nylon
wool and stained with the indi-
cated monoclonal antibodies
and with streptavidin-allophyco-
cyanin (SAv-APC) complexed
Qa-1b tetramer (top). As a con-
trol for the specificity of the tet-
ramer, cells were also stained
with streptavidin-APC alone
(bottom). Left hand panels are
gated on CD3 negative cells,
whereas right hand panels are
gated on CD3 positive cells. The
percentages of gated cells in each
quadrant are indicated, and are
the average of 3 mice 6 SD.
The percentage of APC1 cells
among NK1.11 cells is given in
parentheses. (B) The receptor for
Qa-1b on NK cells only partially
overlaps in its expression with
other class I–specific receptors on
NK cells. NK1.11/tetramer pos-
itive or negative cells were elec-
tronically gated and analyzed for their binding of FITC-conjugated mono-
clonal antibodies to Ly49 family members. Again, the percentage of cells
within the indicated gate is given 6 SD (n 5 3 mice).
Figure 5. (A) Inhibition of NK cells by recognition of Qa-1/Qdm.
Pure IL-2 cultured NK cells (CD32NK1.11) cells were sorted for the ex-
pression (Qa-1tet positive) or the lack of expression (Qa-1tet negative) of
Qa-1b receptor and assayed for cytotoxicity against 51Cr labeled T2 cells
stably transfected with Qa-1b (T2-37, top) or IAb (T2-BB, bottom). Targets
were incubated overnight in media at 268C with the addition of excess
(30 mM) peptide or an equal volume of PBS. Ova (SIINFEKL) is a Kb
binding peptide; Qdm (AMAPRTLLL) is a Qa-1b binding peptide. The
kill was performed in the presence of the peptide/PBS at the indicated E:T
ratios. (B) Treatment with Qdm peptide does not detectably enhance sur-
face expression of Qa-1b in T2-Qa-1b transfectants (T2-37 cells). T2-37
cells were incubated overnight at 268C in the presence of 30 mM peptide
or PBS. To control for the 378C incubation required to label the targets
with 51Cr (see A), the T2-37 cells were then incubated at 378C for 1 h in
the absence of  51Cr but in the presence of appropriate peptide. Cells were
then stained with normal rabbit serum (NRS, dotted histograms) or a spe-
cific rabbit anti-Qa-1b polyclonal antiserum (filled histograms) at 48C in the
presence of sodium azide (0.02%), followed by staining with FITC-con-
jugated swine anti–rabbit F(ab9)2. Numbers indicate the mean fluores-
cence intensity of the population.1846 Mouse CD94/NKG2A Is a Natural Killer Receptor for Qa-1b
However, when the T2-Qa-1b cells were incubated with
excess Qdm peptide (AMAPRTLLL), inhibition of tet-
ramer positive NK cells was observed. As a control, addi-
tion of the Kb binding Ova peptide (SIINFEKL) or PBS
did not inhibit lysis. The effect of the Qdm peptide was
specific since it had no effect on lysis by the tetramer nega-
tive population. Moreover, the inhibition depended on
Qa-1b expression since no inhibition was observed when
Qdm was incubated with T2-IAb (T2-BB) transfectants.
Based on data from the human system, it might be ex-
pected that the sorted tetramer-reactive NK population
would include cells expressing the putative activating re-
ceptor CD94/NKG2C (20). Our results suggest that
Qa-1/Qdm-activated cells must be relatively rare or absent
in B6 mice, or else not dominantly activated in our assay
conditions.
Two nonexclusive hypotheses can be offered to explain
the requirement for peptide addition to observe inhibition.
One is that peptide addition results in higher levels of Qa-1b
on the cell surface, which may be necessary for effective in-
hibitory signaling by the CD94/NKG2 receptor. The
other possibility is that a CD94/NKG2 receptor fails to in-
teract effectively with Qa-1b unless the Qa-1b molecule has
bound peptide. We favor the latter possibility, since neither
we nor others (32) could observe a detectable increase in
the levels of Qa-1b as the result of overnight incubation
with 30 mM peptide (Fig. 5 B). It has not been determined
whether the Qa-1b molecules that are present on the sur-
face of the T2 transfectants before peptide addition are
empty, or are occupied with TAP-independent cellular
peptides (42). The important related question as to whether
the CD94/NKG2A receptor can discriminate between dif-
ferent Qa-1b/peptide complexes remains to be addressed.
Discrimination of class I peptide complexes has been re-
ported in the case of some human (47) but not mouse (48,
49) class I–specific NK receptors.
Our results are significant for several reasons. First, we
provide direct evidence for a physiological receptor for the
nonclassical class I molecule, Qa-1b. Although T cell clones
that recognize Qa-1b can be obtained by alloimmunization
or in other model systems (34, 50, 51), the biological sig-
nificance of these T cell clones has been unclear, as has the
significance of the mysterious observation that Qa-1 binds
peptides derived from the signal sequences of classical class I
proteins. This latter property of Qa-1 can now be rational-
ized in terms of NK function. Second, our results demon-
strate that mouse NK cells express at least two families of
class I-specific receptors, and may consequently help ex-
plain numerous complexities in NK recognition, including
the prior observations that Ly49-negative NK cell lines can
nevertheless detect MHC class I (6, 7). Third, we describe
the first instance in which an NK receptor and its class I
ligand are shared by mice and humans, and therefore pro-
vide the first direct evidence that NK recognition of MHC
class I is a primitive function of NK cells, at a minimum
predating the divergence of mouse and human ancestors.
Our finding that mouse NKG2 genes are clustered within
the NK complex on chromosome six, syntenic with the hu-
man NK complex on chromosome 12, provides additional
support for the notion that the NK complex is itself primi-
tive. Finally, our results will allow the study of CD94 and
NKG2 function in a well-characterized animal model, and
will thus undoubtedly have significance for the study of NK
cell responses to pathogens, tumors and tissue transplants.
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